From the University of Health Sciences, Department of Nuclear Medicine, Istanbul Bagcilar Training and Research Hospital.
University of Health Sciences, Department of Pathology, Istanbul Training and Research Hospital.
Clin Nucl Med. 2023 Apr 1;48(4):e188-e189. doi: 10.1097/RLU.0000000000004550. Epub 2023 Jan 14.
We presented a 69-year-old man with liver cirrhosis who underwent 68 Ga-fibroblast activation protein (FAPI)-04 PET/CT imaging for an ongoing study. In addition to the significant activity in liver cirrhosis on FAPI PET, a primary prostate tumor was incidentally detected with bone metastases. Further, FAPI-negative metastases were not observed on CT evaluation. In this context, we think that FAPI may be helpful with the potential theranostic aspect, especially in selected patients when current treatment options are not applicable or unresponsive. However, we should await the results of prospective studies investigating both prognostic and theranostic use of FAPI and demonstrating its effectiveness in cancer therapy.
我们报告了一位 69 岁的肝硬化患者,他进行了 68Ga-成纤维细胞激活蛋白(FAPI)-04 PET/CT 成像,以进行一项正在进行的研究。除了 FAPI PET 上肝硬化的显著活性外,还意外地发现原发性前列腺肿瘤伴有骨转移。此外,CT 评估未发现 FAPI 阴性转移。在这种情况下,我们认为 FAPI 可能有助于潜在的治疗方面,特别是在当前治疗方案不适用或无反应的情况下,选择特定患者时。然而,我们应该等待前瞻性研究的结果,这些研究将调查 FAPI 的预后和治疗用途,并证明其在癌症治疗中的有效性。